Recorded Groups

Active Surveillance Prostate Cancer Video Chat, January 14th, 2026

Low/Intermediate PCa Video Chat, January 12, 2026: Using DECIPHER genomic testing to assess cancer agressiveness

Hi-Risk/Recurrent/Advanced PrCa Video Chat, 1/5/26: Like London buses, topics come in clusters this week – post-surgery recurrence, and monotherapy daro

Veterans Video Chat, January 6, 2026: C&P exams when you are 100% permanent and total

Low/Intermediate PCa Video Chat, December 22, 2025: Importance of getting your treatment at a NCCN Member Institution

Veterans Video Chat, December 16, 2025: Considerations when sequeencing multiple VA claims

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Dec 23, 2025: AFib may dictate use of ARSI – 2nd line anti-androgen

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Dec 15, 2025: Finishing 10x Pluvicto; and, following up post-surgery for BRCA germline Gent

Low/Intermediate PCa Video Chat, December 8, 2025: Focal therapy sounds great but has higher risk of recurrence

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Dec 9, 2025: Lotsa confusion throughout this week! To pick just one, Signatera MRD test.

Active Surveillance Prostate Cancer Video Chat, December 10th, 2025

Veterans Video Chat, December 2, 2025: Pursuing VA disability and healthcare benefits simultaneously